Lung Cancer Centre of
Erridge, Dr Sara serridge**[ta]**ffmail.ed.ac.uk
CRUK/07/028: BR14/CATNON (TATA): A randomised controlled trial of temozolomide as adjuvant and/or concurrent treatment in anaplastic (WHO grade III) glioma (EORTC) University College London 01/10/2008
Evan, Professor Gerard gie20**[ta]**.ac.uk
Deconstructing
Evans, Dr Mererid Mererid.Evans**[ta]**es.nhs.uk
CRUK/13/025: PATHOS: Post-operative adjuvant treatment for HPV-positive tumours Velindre NHS Trust 01/05/2014
Evans, Professor T R Jeffry CRUKD/11/003: FACING a Phase I/IIa trial of AZD4547, an FGFR inhibitor, in combination with cisplatin and capecitabine (CX) in patients with locally advanced gastro-oesophageal
CRUKD/14/008 PIONEER A Phase I study of olaparib in combination with chemo-radiation in locally advanced pancreatic
Faivre-Finn, Professor Corinne corinne.fnn**[ta]**istie.nhs.uk
CRUKE/10/034: REST: A randomised trial on chest irradiation in extensive disease small cell lung cancer Christie NHS Foundation Trust 01/04/2010
The above is a list of Cancer Research UK’s active publishable awards as of 30 September 2015.For any further enquiries please contact researcher.comments**[ta]**cer.org.uk.CRUK/12/035: (Isotoxic IMRT Study): Isotoxic Intensity Modulated Radiotherapy (IMRT) in non small cell lung cancer (NSCLC) (co-funded with The British Lung Foundation) University of Manchester 01/04/2013
CRUK/07/005: CONVERT: A 2-arm randomised controlled trial of concurrent chemo-radiotherapy comparing twice-daily and high dose once-daily radiotherapy in patients with limited disease small cell lung cancer University of Manchester 01/02/2007
CRUK/11/052: LungART - A Phase III study comparing post-operative conformal radiotherapy to no postoperative radiotherapy in patients with completely resected non-small cell lung cancer and mediastinal N2 Involvement.University of Manchester 01/02/2012
CRUK/14/025: EORTC- LungTech: Stereotactic Body Radiotherapy (SBRT) of inoperable centrally located non-small cell lung cancer (NSCLC): A phase II study University of Manchester 01/04/2015
Fennell, Professor Dean df132**[ta]**ac.uk
CRUK/11/055: PIN A Randomised phase II trial of Olaparib maintenance versus placebo monotherapy in patients with non-small cell lung cancer (AZ/NCRN) Velindre NHS Trust 01/01/2013
Fenwick, Dr John Development of highly precise dose-escalated, intensifed radiotherapy techniques for treating lung and head-and-neck tumours University of Oxford 01/10/2007
Fielding, Dr Adele a.felding**[ta]**.ac.uk
CRUK/11/028: A Phase 2 study for older patients with Acute Lymphoblastic Leukaemia (UKALL-60) University College London 01/01/2013
CRUK/09/006: UKALL14: An international randomised trial for adults with newly diagnosed acute lymphoblastic
Fischer, Professor Peter peter.fscher**[ta]**tingham.ac.uk
Development of selective CDK9-cyclin T1 pharmacological inhibitors for the treatment of chronic lymphocytic leukaemia (Continuation) University of Nottingham 01/06/2014
Fisher, Dr Abigail abigail.fsher**[ta]**.ac.uk
#innerselfe: making future risk feel real University College London 01/05/2015
Fitzgerald, Dr Niamh niamh.ftzgerald**[ta]**r.ac.uk
The UPPP Project: Assessing politicians' Understanding, cancer risk Perceptions and Policy Positions on alcohol University of Stirling 01/07/2015
The above is a list of Cancer Research UK’s active publishable awards as of 30 September 2015.For any further enquiries please contact researcher.comments**[ta]**cer.org.uk.Fitzgerald, Professor Rebecca Screening for squamous dysplasia and early squamous cancer using the Cytosponge™ University of Cambridge 01/01/2015
FULL STUDY Oesophageal Cancer Clinical and Molecular Stratifcation (OCCAMS) Consortium for ICGC Oesophegal Adenocarcinoma project University of Cambridge 01/04/2012
Fitzgibbon, Professor Jude j.ftzgibbon**[ta]**l.ac.uk
Personalised Epigenetic Therapy for Follicular Lymphoma Queen Mary,
Florey, Dr Oliver Oliver.Florey**[ta]**raham.ac.uk
Regulation of entosis and other macro-scale endocytic processes by non-canonical autophagy Babraham Institute 01/03/2014
Fooks, Dr Gary g.fooks**[ta]**on.ac.uk
Low Visibility Tobacco Industry Political Activity and
Forker (nee Minchell), Dr Laura Hypoxia in soft tissue sarcoma and its effect on prognosis and genomic instability University of Manchester 01/12/2014
Forster, Dr Alice alice.forster**[ta]**.ac.uk
Developing and testing the feasibility and acceptability of a novel mobile phone app to increase habit strength for physical activity: the bank of good times University College London 01/04/2015
Why are girls from Black and Asian minority ethnic backgrounds less likely to receive the human papillomavirus (HPV) vaccine? Developing and testing a complex psychological intervention to increase informed
Forster, Dr Martin CRUKE/14/020: DARWIN 1 - Deciphering Afatinib Response and Resistance With INtratumour heterogeneity University College London 01/03/2015
CRUKD/14/011 ORCA-2: A phase I study of olaparib in addition to cisplatin-based concurrent chemoradiotherapy for patients with high risk locally advanced squamous cell carcinoma of the head and neck (HNSCC) University College London 01/02/2015
Frame, Professor Margaret m.frame**[ta]**ac.uk
Invasion and metastasis; understanding and targeting an adhesion protein network University of Edinburgh 01/05/2013
Franzoso, Professor Dr Guido g.franzoso**[ta]**erial.ac.uk
Roles of NF-kB in the control of inflammation and metabolism in cancer Imperial College London 01/01/2013
The above is a list of Cancer Research UK’s active publishable awards as of 30 September 2015.For any further enquiries please contact researcher.comments**[ta]**cer.org.uk.Fraser, Dr Judith CRUKE/10/033: SOLD: The Synergism Or Long Duration (SOLD) Study Beatson West of Scotland Cancer Centre 01/03/2009
Freemont, Professor Paul p.freemont**[ta]**erial.ac.uk
Structural and mechanistic insights into the regulation of protein degradation by the p97/Cdc48 chaperone Imperial College London 01/01/2012
Frye, Dr Michaela mf364**[ta]**.ac.uk
Cytosine-5 RNA methylation in normal and cancer
Cytosine-5 RNA methylation in normal and cancer
Fuchter, Dr Matthew m.fuchter**[ta]**erial.ac.uk
Development of dual EZH2/EHMT2 inhibitors for the treatment of solid tumours Imperial College London 01/04/2015
Fullagar, Professor Simone s.p.fullagar**[ta]**h.ac.uk
Lessons from citizen led community participation and prevention: How does parkrun
Gallagher, Dr Ferdia fag1000**[ta]**.ac.uk
Development of hyperpolarised carbon-13 MRI as a novel clinical imaging tool in
Gallagher, Dr Marie marie.gallagher1**[ta]**r.ac.uk
Evolving Sexual Health eLearning Resources for Further Education Professionals to use with young men: a feasibility study University of Stirling 01/10/2014
Garofalo, Dr Michela Transcriptional Networks in Lung Cancer Cancer Research UK Manchester Institute 01/05/2014
Gartner, Dr Anton Exploring and Exploiting C.elegans as a model to better understand apoptosis induction; combined cytological, genetic and proteomics based approaches University of Dundee 01/07/2012
Gavin, Dr Anna a.gavin**[ta]**.ac.uk
Identifying targets for intervention to promote earlier diagnosis of cancer Queen's University Belfast 01/06/2012
Gaze, Dr Mark mark.gaze**[ta]**h.nhs.uk
CRUK/11/031: LuDo: A Phase II trial of 177 Lutetium DOTATATE in children with primary refractory or relapsed high risk
Georgiou, Dr Marios marios.georgiou**[ta]**tingham.ac.uk
A genetic dissection of tumour progression and invasion in the context of a living epithelium University of Nottingham 01/11/2011
Gergely, Dr Fanni Centrosome Biology Laboratory Cancer Research UK Cambridge Institute 01/04/2012
The above is a list of Cancer Research UK’s active publishable awards as of 30 September 2015.For any further enquiries please contact researcher.comments**[ta]**cer.org.uk.Gerhardt, Dr Holger Mechanisms of vascular patterning in development and disease - FROM CELLS TO NETWORKS The Francis Crick Institute 01/06/2013
Gerlinger, Dr Marco marco.gerlinger**[ta]**.ac.uk
Genetic profling and targeting of heterogeneous and evolving colorectal and renal cancers Institute of Cancer Research 01/10/2014
Ghaneh, Professor Paula p.ghaneh**[ta]**erpool.ac.uk
CRUK/12/045: ESPAC
CRUK/12/045: European Study Group for Pancreatic Cancer Trial
Gibson, Professor Brenda brenda.gibson**[ta]**.scot.nhs.uk
CRUK/14/013: An international randomised phase III clinical trial in children with acute myeloid leukaemia (MyeChild01).University of Birmingham 01/10/2014
Gilbert, Dr Rebecca becky.gilbert**[ta]**stol.ac.uk
Improving the detection of localised prostate cancer by combining longitudinal reference ranges, clinical prediction rules and genetic
Gilbert, Professor Robert gilbert**[ta]**ubi.ox.ac.uk
Identifying small-molecule inhibitors of cancer-related cytoplasmic uridylyltransferase activities controlling tumour-suppressor miRNA
Gilmore, Professor Anna UKCTAS Communications and Research Network Manager University of Bath 01/12/2014
Glasspool, Dr Rosalind ros.glasspool**[ta]**il.com CRUKE/12/024: A randomised phase II study of BIBF 1120 compared to chemotherapy in patients with recurrent clear cell carcinoma of the ovary or endometrium NHS Greater Glasgow and Clyde 01/09/2014
CRUKE/12/024: Nintedanib in Clear Cell Carcinoma - sample collection for translational studies NHS Greater Glasgow and Clyde 01/09/2014
Glennie, Professor Martin mjg**[ta]**on.ac.uk
Developing Immunomodulatory Monoclonal Antibodies to Promote
Glover, Professor David Regulation of the mitotic apparatus by Aurora- and Polo-like kinases University of Cambridge 01/10/2010
Goehring, Dr Nathan Developmental Systems The Francis Crick Institute 01/03/2013
The above is a list of Cancer Research
Evaluation of treatment response and resistance in metastatic renal cell cancer using integrated positron emission tomography/magnetic resonance imaging (PET/MRI) with
Gottlieb, Professor Eyal e.gottlieb**[ta]**tson.gla.ac.uk
Identifying and targeting metabolic vulnerabilities of cancer cells Cancer Research UK Beatson Institute 01/03/2014
Gourley, Professor Charlie charlie.gourley**[ta]**ac.uk
CRUKE/12/028: LOGS Study- A randomised 2 arm phase III study to assess the efcacy of MEK inhibitor GSK
Grabsch, Professor Heike h.i.grabsch**[ta]**ds.ac.uk
Sample collection, sample preparation and central pathology review including slide scanning from patients with operable oesophageal cancer recruited into the UK NCRI OE05 trial University of Leeds 01/01/2013
Gray, Dr Juliet jcgray**[ta]**on.ac.uk
CRUK/11/035: A Phase I/II dose schedule fnding study of CH14.18/CHO continuous infusion combined with subcutaneous Aldesleukin IL
Green, Professor Anthony arg1000**[ta]**.ac.uk
CRUK/08/003: COSMYD: A Collaborative Study of Myeloproliferative Disorders University of Cambridge 01/05/2008
Transcriptional programmes of myeloproliferative
Greenhalf, Dr William greenhaf**[ta]**erpool.ac.uk
Stratifcation of adjuvant chemotherapeutic response to allow personalised choice of pyrimidine prodrug: based on levels of transporters and enzymes involved in initial
- 項目對接快訊
-
- 最新信息
- 熱門信息
